April 10 (Reuters) - U.S. healthcare company PACS Group ( PACS )

set the pricing of its initial public offering at $21 per share,

to raise around $450 million, it said on Wednesday.

The company priced its IPO at the mid-point of its

previous target range of $20 to $22, valuing it at around $3.1

billion based on the outstanding shares listed in its filing

with the U.S. Securities and Exchange Commission.

The firm will debut on the New York Stock Exchange on

Thursday under the symbol "PACS".

According to its release, PACS focuses on delivering

nursing care through a portfolio of independently operated

facilities.

After a two-year dry spell, U.S. IPOs are expected to

rebound in 2024 on firming bets of a soft landing for the

world's largest economy, although the recovery has been uneven

so far.

Since the beginning of the year, Healthcare companies CG

Oncology ( CGON ) and KKR-backed BrightSpring Health Services

have made contrasting market debuts, signaling

investors remained cautious.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Varun H K)